Epidemiology and global impact of chronic obstructive pulmonary disease, Semin Respir Crit Care Med, vol.26, issue.2, pp.204-210, 2005. ,
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary, Eur Respir J, vol.49, p.3, 2017. ,
Epidemiology and prevalence of chronic obstructive pulmonary disease, Clin Chest Med, vol.35, issue.1, pp.7-16, 2014. ,
Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique, Int J Chron Obstruct Pulmon Dis, vol.13, pp.57-67, 2018. ,
Impact of chronic airflow obstruction in a working population, Eur Respir J, vol.31, issue.6, pp.1227-1233, 2008. ,
, INSERM. Bronchopneumopathie chronique obstructive (BPCO
Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf, vol.19, pp.256-265, 2010. ,
Value of a national administrative database to guide public decisions: from the systeme national d'information interregimes de l'Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France, Rev Epidemiol Sante Publique, vol.65, issue.4, pp.149-167, 2017. ,
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease, N Engl J Med, vol.356, issue.8, pp.775-789, 2007. ,
Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial, Lancet, vol.374, issue.9696, pp.61298-61306, 2009. ,
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review ,
, Respir Res, vol.17, issue.1, p.112, 2016.
Medication compliance and persistence: terminology and definitions. Value Health, vol.11, pp.44-47, 2008. ,
Treatment persistence and compliance with medications for chronic obstructive pulmonary disease, Can Respir J, vol.14, issue.1, pp.25-29, 2007. ,
, Etude épidémiologique sur la BPCO: Synthèse. Ministère de la Santé, 2007.
Non-persistence and non-adherence to long-acting COPD medication therapy: a retrospective cohort study based on a large German claims dataset, Respir Med, vol.122, pp.1-11, 2017. ,
COPD routine management in France: are guidelines used in clinical practice?, Rev Mal Respir, vol.27, issue.1, pp.11-18, 2010. ,
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease, Eur Respir J, vol.18, issue.6, pp.903-908, 2001. ,
Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal, NPJ Prim Care Respir Med, vol.26, p.16068, 2016. ,
Enhanced persistence with tiotropium compared with other respiratory drugs in COPD, Respir Med, vol.101, issue.7, pp.1398-1405, 2007. ,
Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease, Int J Geriatr Psychiatry, vol.29, issue.1, pp.49-57, 2014. ,
Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population ,
, Am J Geriatr Pharmacother, vol.10, issue.3, pp.201-210, 2012.
Factors associated with medication adherence in patients with chronic obstructive pulmonary disease, Respiration, vol.82, issue.4, pp.328-334, 2011. ,
Adherence to maintenance medications among older adults with chronic obstructive pulmonary disease. The role of depression, Ann Am Thorac Soc, vol.13, issue.9, pp.1497-1504, 2016. ,
Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD), J Gen Intern Med, vol.9, issue.3, pp.1506-1512, 2012. ,
Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease, Chron Respir Dis, vol.10, issue.1, pp.11-18, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02281835
Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers ,
, J Med Econ, vol.14, issue.4, pp.486-496, 2011.
The SCOPE study: healthcare consumption related to patients with chronic obstructive pulmonary disease in France. Value Health, vol.7, pp.168-174, 2004. ,
Prs2 cost of Chronic Bronchitis (Cb) and Chronic Obstructive Pulmonary Disease (Copd) in France: the Broncheco study, Value Health, vol.7, p.6, 2004. ,
,
, Rev Mal Respir, vol.32, issue.7, pp.682-691, 2015.
Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population ,
, Int J Chron Obstruct Pulmon Dis, vol.7, pp.757-764, 2012.
Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care, Respir Res, vol.16, p.141, 2015. ,
Impact of nonadherence to inhaled corticosteroid/LABA therapy on COPD exacerbation rates and healthcare costs in a commercially insured US population, Am Health Drug Benefits, vol.10, issue.2, pp.92-102, 2017. ,
Ten-year trends in direct costs of COPD: a population-based study, Chest, vol.148, issue.3, pp.640-646, 2015. ,
Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD), Eur J Clin Pharmacol, vol.68, issue.10, pp.1365-1373, 2012. ,
Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy, Geriatr Gerontol Int, vol.17, issue.12, pp.2500-2506, 2017. ,
Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients, Chron Respir Dis, vol.13, issue.1, pp.13-22, 2016. ,
Correlates of adherence to respiratory drugs in COPD patients, Prim Care Respir J, vol.19, issue.2, pp.148-154, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01838988
Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study, Int J Chron Obstruct Pulmon Dis, vol.13, pp.2557-2568, 2018. ,
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD, Eur Respir J, vol.22, issue.2, pp.286-289, 2003. ,
Chronic obstructive pulmonary disease exacerbation and inhaler device handling: reallife assessment of 2935 patients, Eur Respir J, vol.49, issue.2, 2017. ,
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting ?2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial, Lancet, vol.388, issue.16, p.31354, 2016. ,
Once-daily single-inhaler triple versus dual therapy in patients with COPD, N Engl J Med, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02056333
, DovePress International Journal of Chronic Obstructive Pulmonary Disease, vol.2019, p.14
, International Journal of Chronic Obstructive Pulmonary Disease, vol.117, issue.30, 2020.